Really pleased to Chair this valuable and insightful session on the Cancer Plan with 70+ colleagues from across the cancer community. Huge opportunity to improve outcomes for people affected by cancer 🙌 #BloodCancerAlliance
@lesssurvivable.bsky.social #Cancer52 #OneCancerVoice

Blood cancer patients face treatment access disparity - PharmaTimes New research highlights NHS approval gap compared to other cancers

#healthinequalities #Bloodcancer #Bloodcancerpatients #Bloodcancertreatment #BloodCancerAlliance #bloodcancertreatments #NICEapproval #pharmaceuticalcompanies #NICEappraisals #patientoutcomes #CARTtherapy #CiltaCel #myeloma #NICEappraisalprocesses #patientaccess
pharmatimes.com/news/blood-c...